DBV Technologies (DBVT) Change in Cash (2014 - 2026)
DBV Technologies (DBVT) reported Change in Cash of $35.0 million for Q1 2026, up 279.49% year-over-year from $9.2 million in Q1 2025, and down 71.85% on a QoQ basis from $124.3 million in Q4 2025.
DBV Technologies (DBVT) has 13 years of Change in Cash data on file, last reported at $35.0 million in Q1 2026.
- Quarterly Change in Cash rose 279.49% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216.2 million (up 344.11% YoY) and the FY2025 annual result came in at $161.7 million, up 248.48% from the prior year.
- Change in Cash fell to $35.0 million in Q1 2026 per DBVT's latest filing, from $124.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $173.9 million in Q2 2022 and bottomed at -$39.8 million in Q1 2024.
- The 5-year median for Change in Cash is -$16.9 million (2023), against an average of $8.9 million.
- The widest annual swing landed in 2023, when Change in Cash sank 429.27%; it then surged 988.83% in 2025.
- Tracing DBVT's Change in Cash over 5 years: stood at -$3.5 million in 2022, then sank by 123.48% to -$7.8 million in 2023, then tumbled by 80.07% to -$14.0 million in 2024, then surged by 988.83% to $124.3 million in 2025, then slumped by 71.85% to $35.0 million in 2026.
- Per Business Quant, the three latest DBVT Change in Cash figures stand at $35.0 million (Q1 2026), $124.3 million (Q4 2025), and -$33.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 35.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 124.33 Mn |
| Sep 30, 2025 | -33.37 Mn |
| Jun 30, 2025 | 90.25 Mn |
| Mar 31, 2025 | -19.50 Mn |
| Dec 31, 2024 | -13.99 Mn |
| Sep 30, 2024 | -19.77 Mn |
| Jun 30, 2024 | -35.31 Mn |
| Mar 31, 2024 | -39.84 Mn |
| Dec 31, 2023 | -7.77 Mn |
| Sep 30, 2023 | -24.83 Mn |
| Jun 30, 2023 | -18.33 Mn |
| Mar 31, 2023 | -16.91 Mn |
| Dec 31, 2022 | -3.48 Mn |
| Sep 30, 2022 | -35.30 Mn |
| Jun 30, 2022 | 173.86 Mn |
| Mar 31, 2022 | -3.19 Mn |
| Dec 31, 2021 | -20.89 Mn |
| Sep 30, 2021 | -27.29 Mn |
| Jun 30, 2021 | -26.98 Mn |
| Mar 31, 2021 | -43.89 Mn |
| Dec 31, 2020 | -25.05 Mn |
| Sep 30, 2020 | -31.51 Mn |
| Jun 30, 2020 | -34.52 Mn |
| Mar 31, 2020 | 94.19 Mn |
| Dec 31, 2019 | 126.46 Mn |
| Sep 30, 2019 | -55.05 Mn |
| Jun 30, 2019 | -17.48 Mn |
| Dec 31, 2018 | -16.65 Mn |
| Sep 30, 2018 | 21.02 Mn |
| Dec 31, 2017 | -143.49 Mn |
| Dec 31, 2016 | -71.45 Mn |
| Dec 31, 2015 | -11.03 Mn |
| Dec 31, 2014 | -12.92 Mn |